pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4254 |
Genomic Coordinates | chr1: 31758660 - 31758735 |
Description | Homo sapiens miR-4254 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4254 | ||||||||||||||||||
Sequence | 44| GCCUGGAGCUACUCCACCAUCUC |66 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | SOLiD | ||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ZNF486 | ||||||||||||||||||||
Synonyms | KRBO2 | ||||||||||||||||||||
Description | zinc finger protein 486 | ||||||||||||||||||||
Transcript | NM_052852 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ZNF486 | |||||||||||||||||||||
3'UTR of ZNF486 (miRNA target sites are highlighted) |
>ZNF486|NM_052852|3'UTR 1 CAAAGGATTATTTTATTATTATTATTTTTTTGAGAGGTAATTCTGCTGTTGTTTCCCAGGCTGGAGTGCAATGGCATAAT 81 TTTGGCTCACCACAACCTCCACCTTCTGGGTTCAAGTAACTCTCCTTAGTAGCTAGGATTACAGGGCTGCACCACCACAC 161 CTGGCTAATTTTGTATTTTTAGTAGAGATGGGGTTTCTCCATGTTGGTCAGGCTGGTCTCAATCTCCTAACCTCAGGTGG 241 TCTGCCTGCTTTGGCCTCCCAAAGTGTTGGGGTTACAGGCATGAGCCACTGTGCCTGGCTGACAAAGCTTTTTAAGGAAG 321 TTCTCAACCCTTATTACACATAATTCATACTGGACAGAAACCCTACAAGTGTGAAGAATGTGGCAAGCCTGTAACAAGTT 401 CTCAATTCTTTTATTTTTATTTGTTTATTTATTTTTTGAGATGCAGTTTCACTCTTGTGACCCGGGCTGTAGTGCAATGG 481 CATGATCTTGGCTTACTGTGACCTCTGCCTCCTGGGTTCAAGCCATTCTCCTGCCTCAGCCTCCCAAGTAGCTGGGATTA 561 CAGGTGCCACCACCATTCCCAGCTAATTTTTGTATTTTTAGTAGAGATGGGCTTTTGCCATATTTGCCAGGCTGGTCTCA 641 AACTCCTGACCTCAGGTGATCCACTCGCCTCGGCTTCCTAAAGTGCTGGGATGACAGGCATGAGCCTCAATTCCCAGCCA 721 TAAGCTCTTAATTCTTAAGAGACATGGCGATAATTCATGGTGAAGAGGAACTTTACAAACCTGAAAGATGTGACAGTGCT 801 TTTCCCAACACCTCCAACTTTTCTATGCATAAAAAAAATTATACTACACCATAGAAATGTATGAAATGTGACAAAGCCTT 881 TATATGGTTGCCACACTTTATTGTAGGTAATTCATACTTCCAAAATACCTACAAGTATGAAGAATGTGGCAAAACTTTTA 961 ATCAGTGCTTACACCGTATTTCACAGGAAAGCTATTATCCTTGAGAAAAATTGTACAAATATAAAGAATATGGAAAAGCC 1041 ATTAATGTCCATCACATCTTACTCAACAGAAGAAGGTTCATAAAAGAGCAATTACTGTGACAAAAATCTTTCAGAAAATA 1121 TAAGCCTTTAAGGTGAAGAAGAGTATTGATTCTGAAGACAAGCATTACAAATATAAAGAGGTTTGTAGTACCTTTGCTTG 1201 TATTACAGATCTTATTGCCCGCGTTTTGTATTAGAAGGAAACCCTAAAGCGGTTGCCAAACTTTGTGCAACATCAGGGAA 1281 TGTATATTGAAGAAGATTCCTGCAAATGTAATGAGTTTGGAAACACTTCTTAGATAAATTATTTGTGGCTGGGCACAGTG 1361 GCTCATGCCTGTAATCCCAGCACTTTGGGAGGCCAAGGTGGGAGGATCACCTGATGTCGGGAGTTTGAGATCAGACTGAC 1441 CAAAACGGAGAAACCCAGTCTCTACTGAAAATATAAAATTAGCCATGCATGGTGGCACATGCCTGTAATCCCAGCTACTC 1521 AGGAGGCTTGAACCCTGGAGGCAGAGGTTGTGGTGAGTCGAGATCATTGCACTCCAGCCTGGGCAATAAGAGTGAAACTC 1601 TGTCTCCAGGAAAAAAAAAAATTTATTTGTGTATAACTTTAAAAGCAGATTTTTGGAAGCATTGTAATTACATTAAAAGT 1681 ATACTTGTTCCAGCTGCGTGTGGTGGCTCATGCCTGTAATCCCAACACTTTGGGAGGCCAAGGCAGGTGGATCACGAGGT 1761 CAGGAGTTCAAGACCATCTTGGCCAAGATGGTGAAACCCTGTCTGTACTAAAAATACAAAAATTAGCCATGCATGGTGGC 1841 CGGCGCGTATAATCCCAGCTGCTTGGGAGGCTGAGGCAGAGAATTGGAATTGCTTGAACCTGGGAGGTGGAGGTTGCAGT 1921 GAGCCGAGGTTGCACCATTGTCCAGCCTGGGCAACAGAGCAAGACTCCATCTCAAAAAAAAAAGTGTATTTGTTTCCTTA 2001 AAAAAATTTTTCTGAAAAGTGGGTAATGACATAATACAGCTTTCAAATTACTTTATGCTGTTATTTTATTCTTATTGTAT 2081 TCACATGTGAAAGCATGTGATCAATTTTTGCTGCATCAGAGATATTAGAGATAGTTTTTTATTAATTGGGCATTTATGAC 2161 CTTTTCTATAAAAGTAAGGACATTAAAATGTAAGATGCATGATGAAAATATAAGTGGAGAGGCTCTTTGTAGTTAACCTA 2241 TATGAAGTAATGTATAAGGTAGGTCAGAGTAATACTTTTCTACATTATAGTGCAAGAAATAATTATTGATAAAAGTATAT 2321 TAAACTAAATTCGTATATTTTACTTATTGTACTTTTATGTAATAAAATGCAGTGCATTTAAAAATTGT Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293S | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1084069. RNA binding protein: AGO2. Condition:CLIP_emetine_SigmaAb
HITS-CLIP data was present in GSM1084083. RNA binding protein: AGO2. Condition:CLIP_hippuristanol_rep2_SigmaAb
... - Karginov FV; Hannon GJ, 2013, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Karginov FV; Hannon GJ - Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
|
CLIP-seq Support 1 for dataset GSM1084069 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_emetine_SigmaAb |
Location of target site | ENST00000335117.8 | 3UTR | CCAGGAAAAAAAAAAAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1084083 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_hippuristanol_rep2_SigmaAb |
Location of target site | ENST00000335117.8 | 3UTR | UCCAGGAAAAAAAAAAAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
57 hsa-miR-4254 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT061595 | BTG2 | BTG anti-proliferation factor 2 | 2 | 4 | ||||||||
MIRT306302 | ABCC5 | ATP binding cassette subfamily C member 5 | 2 | 2 | ||||||||
MIRT353697 | ACTR2 | ARP2 actin related protein 2 homolog | 2 | 2 | ||||||||
MIRT442351 | RAB6B | RAB6B, member RAS oncogene family | 2 | 2 | ||||||||
MIRT448535 | RIMS4 | regulating synaptic membrane exocytosis 4 | 2 | 2 | ||||||||
MIRT449881 | CYP3A5 | cytochrome P450 family 3 subfamily A member 5 | 2 | 2 | ||||||||
MIRT457644 | ZNF69 | zinc finger protein 69 | 2 | 2 | ||||||||
MIRT458620 | TRIM72 | tripartite motif containing 72 | 2 | 2 | ||||||||
MIRT470963 | PKM | pyruvate kinase, muscle | 2 | 2 | ||||||||
MIRT476285 | GMFB | glia maturation factor beta | 2 | 10 | ||||||||
MIRT477615 | EFNA3 | ephrin A3 | 2 | 2 | ||||||||
MIRT482761 | TMEM126B | transmembrane protein 126B | 2 | 2 | ||||||||
MIRT492535 | PSMD11 | proteasome 26S subunit, non-ATPase 11 | 2 | 2 | ||||||||
MIRT502995 | CCDC71L | coiled-coil domain containing 71 like | 2 | 8 | ||||||||
MIRT508467 | HOXB6 | homeobox B6 | 2 | 4 | ||||||||
MIRT520190 | WBP2 | WW domain binding protein 2 | 2 | 2 | ||||||||
MIRT525117 | PRKD2 | protein kinase D2 | 2 | 2 | ||||||||
MIRT525773 | SOD2 | superoxide dismutase 2 | 2 | 2 | ||||||||
MIRT526411 | TFAM | transcription factor A, mitochondrial | 2 | 2 | ||||||||
MIRT528152 | AGTPBP1 | ATP/GTP binding protein 1 | 2 | 2 | ||||||||
MIRT534111 | SOGA3 | SOGA family member 3 | 2 | 2 | ||||||||
MIRT538026 | DNAJC10 | DnaJ heat shock protein family (Hsp40) member C10 | 2 | 2 | ||||||||
MIRT539288 | ANGEL2 | angel homolog 2 | 2 | 2 | ||||||||
MIRT541103 | RAF1 | Raf-1 proto-oncogene, serine/threonine kinase | 2 | 2 | ||||||||
MIRT550999 | SUOX | sulfite oxidase | 2 | 2 | ||||||||
MIRT562165 | HOXA13 | homeobox A13 | 2 | 2 | ||||||||
MIRT570122 | CACNG8 | calcium voltage-gated channel auxiliary subunit gamma 8 | 2 | 2 | ||||||||
MIRT571104 | DENND4B | DENN domain containing 4B | 2 | 2 | ||||||||
MIRT574099 | VASN | vasorin | 2 | 2 | ||||||||
MIRT611153 | ZNF486 | zinc finger protein 486 | 2 | 2 | ||||||||
MIRT612252 | STX1B | syntaxin 1B | 2 | 4 | ||||||||
MIRT614808 | RIOK3 | RIO kinase 3 | 2 | 2 | ||||||||
MIRT622153 | SORBS2 | sorbin and SH3 domain containing 2 | 2 | 2 | ||||||||
MIRT624286 | CRCP | CGRP receptor component | 2 | 2 | ||||||||
MIRT624875 | ABCC12 | ATP binding cassette subfamily C member 12 | 2 | 2 | ||||||||
MIRT627479 | STRN | striatin | 2 | 2 | ||||||||
MIRT641273 | AMDHD2 | amidohydrolase domain containing 2 | 2 | 2 | ||||||||
MIRT645622 | TSPAN6 | tetraspanin 6 | 2 | 2 | ||||||||
MIRT650226 | SIGLEC9 | sialic acid binding Ig like lectin 9 | 2 | 2 | ||||||||
MIRT657507 | HBEGF | heparin binding EGF like growth factor | 2 | 2 | ||||||||
MIRT660811 | AHCY | adenosylhomocysteinase | 2 | 2 | ||||||||
MIRT667439 | METTL14 | methyltransferase like 14 | 2 | 2 | ||||||||
MIRT693744 | ACACA | acetyl-CoA carboxylase alpha | 2 | 2 | ||||||||
MIRT697852 | UBE2Z | ubiquitin conjugating enzyme E2 Z | 2 | 2 | ||||||||
MIRT698719 | SUMO2 | small ubiquitin-like modifier 2 | 2 | 2 | ||||||||
MIRT699980 | RREB1 | ras responsive element binding protein 1 | 2 | 2 | ||||||||
MIRT700689 | POLR3D | RNA polymerase III subunit D | 2 | 2 | ||||||||
MIRT703267 | GNL3L | G protein nucleolar 3 like | 2 | 2 | ||||||||
MIRT703787 | FAM102B | family with sequence similarity 102 member B | 2 | 2 | ||||||||
MIRT711277 | SDR9C7 | short chain dehydrogenase/reductase family 9C member 7 | 2 | 2 | ||||||||
MIRT711863 | TRAF2 | TNF receptor associated factor 2 | 2 | 2 | ||||||||
MIRT712451 | KHNYN | KH and NYN domain containing | 2 | 2 | ||||||||
MIRT714449 | UBXN2A | UBX domain protein 2A | 2 | 2 | ||||||||
MIRT718846 | SNX20 | sorting nexin 20 | 2 | 2 | ||||||||
MIRT721333 | IFNAR2 | interferon alpha and beta receptor subunit 2 | 2 | 2 | ||||||||
MIRT723315 | PRKCH | protein kinase C eta | 2 | 2 | ||||||||
MIRT736659 | CYP2B6 | cytochrome P450 family 2 subfamily B member 6 | 1 | 0 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|